Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Neoplasm Metastasis/drug therapy"'
Autor:
Joanna Gale, C.L. Ferguson, J. Martin Russell, Prabir Chakraborti, Carys Thomas, Mohan Hingorani, Joe M. O'Sullivan, Anjali Zarkar, Clare Gilson, Zafar Malik, John Wagstaff, Jo Bowen, Fiona McKinna, Angus Robinson, Claire Amos, Simon Chowdhury, Alison Birtle, Fawzi Adab, Peter Hoskin, San Aung, Robin Millman, Chris Parker, Neil McPhail, Alastair W. S. Ritchie, Robert Jones, Jason F. Lester, Noel W. Clarke, Susannah Brock, Gerhardt Attard, Andrew Protheroe, James D. Wylie, Omi Parikh, Johann S. de Bono, Nicholas D. James, Julian Money-Kyrle, Malcolm David Mason, William Cross, Emma Gray, David Matheson, Dominik Berthold, Silke Gillessen, Melissa R. Spears, David P. Dearnaley, Narayanan Srihari, Matthew R. Sydes, Mahesh K.B. Parmar, Chris Brawley
Publikováno v:
STAMPEDE investigators 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
STAMPEDE Investigators & Gillessen, S 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', The New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
The New England journal of medicine, vol. 377, no. 4, pp. 338-351
STAMPEDE Investigators & Gillessen, S 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', The New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
The New England journal of medicine, vol. 377, no. 4, pp. 338-351
BACKGROUND: Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae654176b4379045bb5aaa6609f18434
https://pure.qub.ac.uk/en/publications/bca063cc-7a5e-46eb-95d8-7e27f2cf88b6
https://pure.qub.ac.uk/en/publications/bca063cc-7a5e-46eb-95d8-7e27f2cf88b6
Autor:
Wim P. Ceelen, Edward Levine
Intraperitoneal Cancer Therapy: Principles and Practice is one of the first books to combine the latest clinical developments in the treatment of patients with peritoneal surface disease and the scientific principles that underlie the concept of intr
Publikováno v:
Acta Médica Portuguesa; v. 29, n. 7-8 (2016): Julho-Agosto; 456-460
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Introdução: A carcinomatose meníngea consiste na infiltração de células tumorais ao longo das leptomeninges e espaço subaracnoideu, encontrando-se associada a uma sobrevida média de 2 - 5 meses. As indicações sobre a modalidade mais adequad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fe38264cf3511a0da8d1a4af4bffb4
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6733
Publikováno v:
Cancer treatment reviews
Background: Gene expression profiling platforms were recently shown to accurately assign cancer of unknown primary (CUP) to a primary tissue of origin, with unknown impact on patient outcome. We examined chemotherapy activity and outcome in CUP trial
Autor:
Lee D. Cranmer, Sigrun Hallmeyer, Rene Gonzalez, Anna C. Pavlick, John D. Hainsworth, F. Stephen Hodi, Lynn M. Schuchter, Bann Mo Day, C. Lance Cowey, David F. McDermott, David H. Lawson, R. Linke, Fred J. Kudrik, Brendan D. Curti, Paul B. Chapman, Kim Margolin, Keith T. Flaherty, Omid Hamid, Gerald P. Linette, Antoni Ribas, Lawrence E. Flaherty
Publikováno v:
Cancer journal (Sudbury, Mass.), vol 20, iss 1
Purpose This open-label, multicenter study was designed to allow access to vemurafenib for patients with metastatic melanoma, bridging the time between end of enrollment in the phase III registration trial (December 2010) and commercial availability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3953e48760c3f30385fbbce2f234de
https://escholarship.org/uc/item/6jv605j1
https://escholarship.org/uc/item/6jv605j1
Autor:
Pentheroudakis, George, Fountzilas, George, Kalofonos, H. P., Golfinopoulos, Vassilis, Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Papakostas, P., Pectasides, Dimitrios, Christodoulou, C., Syrigos, K., Economopoulos, T., Pavlidis, Nicholas
Publikováno v:
Critical reviews in oncology/hematology
Introduction: Cancer in the elderly is a common health issue in developed societies. We sought to present epidemiology, management and outcome data on fit elderly patients with common metastatic cancers and to identify predictors of clinical benefit
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.